https://www.selleckchem.com/pr....oducts/ly3023414.htm
The role of neoadjuvant chemotherapy (NACT) is under investigation in locally advanced cervical cancer (LACC). A total of 49 patients with FIGO stage IB1-IIB cervical cancer who underwent two different regimens of weekly dose-dense NACT were included. The objective was to evaluate clinical/pathological response and toxicity profile. A clinical complete response and partial response were obtained in 43 patients with a clinical overall response rate of 88%. Among the 42 surgically treated patients, 7 (17%) and 35 (83%) achieved a pathol
Like
Comment
Share
